Growth Metrics

Conmed (CNMD) Non-Current Deferred Tax Liability (2016 - 2026)

Conmed filings provide 17 years of Non-Current Deferred Tax Liability readings, the most recent being $81.4 million for Q1 2026.

  • On a quarterly basis, Non-Current Deferred Tax Liability rose 16.33% to $81.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $81.4 million, a 16.33% increase, with the full-year FY2025 number at $79.5 million, down 55.11% from a year prior.
  • Non-Current Deferred Tax Liability hit $81.4 million in Q1 2026 for Conmed, up from $79.5 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $177.2 million in Q4 2024 to a low of $60.9 million in Q4 2023.
  • Median Non-Current Deferred Tax Liability over the past 5 years was $66.9 million (2023), compared with a mean of $79.7 million.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: soared 190.91% in 2024 and later tumbled 55.11% in 2025.
  • Conmed's Non-Current Deferred Tax Liability stood at $66.7 million in 2022, then fell by 8.73% to $60.9 million in 2023, then surged by 190.91% to $177.2 million in 2024, then tumbled by 55.11% to $79.5 million in 2025, then grew by 2.32% to $81.4 million in 2026.
  • The last three reported values for Non-Current Deferred Tax Liability were $81.4 million (Q1 2026), $79.5 million (Q4 2025), and $74.9 million (Q3 2025) per Business Quant data.